Non-invasive medical device maker OrthoCor said yesterday it was acquired by veterinary-focused medical device firm Caerus Corp, who said the company will remain independent and focused on the orthopedic market.
OrthoCor’s flagship product is its Active System, which uses pulsed electromagnetic field technology to reduce joint pain and restore physical function to patients, the company said.
“This unique partnership will allow us to take OrthoCor’s technology into new pain management markets while improving the quality of patient care with more diversified product offerings. We plan to leverage our existing orthopedic product portfolio and distribution channels within the veterinary markets to further expand the use of OrthoCor’s Active System in pre & post surgical animal patient care. Furthermore we are excited to join forces with OrthoCor and assist them in fulfilling their vision,” Caerus CEO Fariborz Boor Boor said in prepared remarks.
Post-acquisition, Caerus said that OrthoCor will remain focused on “improving patient recovery” by introducing new PEMF devices for joints and other non-invasive pain management systems.
“OrthoCor’s acquisition marks a pivotal moment for OrthoCor and its key stakeholders. We are thrilled to begin this journey with Fariborz and his team as he brings many years of visionary leadership including his recent successful venture, Exos Medical,” OrthoCor Medical prez John Dinusson said in a press release.